Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #41,901 to #41,950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Acute myeloblastic leukemia (patient information) (2 revisions)
  2. Acute myeloblastic leukemia CT (2 revisions)
  3. Acute myeloblastic leukemia MRI (2 revisions)
  4. Acute myeloblastic leukemia causes (2 revisions)
  5. Acute myeloblastic leukemia chest x ray (2 revisions)
  6. Acute myeloblastic leukemia cost-effectiveness of therapy (2 revisions)
  7. Acute myeloblastic leukemia differential diagnosis (2 revisions)
  8. Acute myeloblastic leukemia epidemiology and demographics (2 revisions)
  9. Acute myeloblastic leukemia future or investigational therapies (2 revisions)
  10. Acute myeloblastic leukemia historical perspective (2 revisions)
  11. Acute myeloblastic leukemia history and symptoms (2 revisions)
  12. Acute myeloblastic leukemia laboratory tests (2 revisions)
  13. Acute myeloblastic leukemia medical therapy (2 revisions)
  14. Acute myeloblastic leukemia natural history (2 revisions)
  15. Acute myeloblastic leukemia other diagnostic studies (2 revisions)
  16. Acute myeloblastic leukemia pathophysiology (2 revisions)
  17. Acute myeloblastic leukemia physical examination (2 revisions)
  18. Acute myeloblastic leukemia primary prevention (2 revisions)
  19. Acute myeloblastic leukemia risk factors (2 revisions)
  20. Acute myeloblastic leukemia screening (2 revisions)
  21. Acute myeloblastic leukemia secondary prevention (2 revisions)
  22. Acute myeloblastic leukemia surgery (2 revisions)
  23. Acute myeloblastic leukemia with maturation (2 revisions)
  24. Acute myeloblastic leukemia without maturation (2 revisions)
  25. Acute myeloid leukemia case studies (2 revisions)
  26. Acute myeloid leukemia future or investigational therapies (2 revisions)
  27. Acute myeloid leukemia other imaging findings (2 revisions)
  28. Acute myeloid leukemia primary prevention (2 revisions)
  29. Acute myeloid leukemia secondary prevention (2 revisions)
  30. Acute myelomonocytic leukemia (2 revisions)
  31. Acute pancreatitis cost-effectiveness of therapy (2 revisions)
  32. Acute pancreatitis future or investigational therapies (2 revisions)
  33. Acute posthemorrhagic anemia (2 revisions)
  34. Acute promyelocytic leukemia Screening (2 revisions)
  35. Acute promyelocytic leukemia other imaging findings (2 revisions)
  36. Acute renal failure echocardiography or ultrasound (2 revisions)
  37. Acute renal failure screening (2 revisions)
  38. Acute respiratory distress syndrome diagnostic study of choice (2 revisions)
  39. Acute tubular insufficiency (2 revisions)
  40. Acute tubular necrosis surgery (2 revisions)
  41. Acute uric acid nephropathy CT (2 revisions)
  42. Acute uric acid nephropathy KUB x ray (2 revisions)
  43. Acute uric acid nephropathy MRI (2 revisions)
  44. Acute uric acid nephropathy case study one (2 revisions)
  45. Acute uric acid nephropathy classification (2 revisions)
  46. Acute uric acid nephropathy cost-effectiveness of therapy (2 revisions)
  47. Acute uric acid nephropathy differential diagnosis (2 revisions)
  48. Acute uric acid nephropathy epidemiology and demographics (2 revisions)
  49. Acute uric acid nephropathy future or investigational therapies (2 revisions)
  50. Acute uric acid nephropathy historical perspective (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)